EDN1 and Alzheimer disease: Whereas ET-1 production is significantly increased in the cerebral cortex in AD, presumably reflecting locally elevated Aβ and oxidative stress, it is reduced in the white matter, as would be expected for a physiological adaptation to reduced blood flow.